![]() |
Name |
Isochromophilone V
|
Molecular Formula | C19H23ClO4 | |
IUPAC Name* |
(7R,8R)-5-chloro-3-[(1E,3E,5S)-3,5-dimethylhepta-1,3-dienyl]-7,8-dihydroxy-7-methyl-8H-isochromen-6-one
|
|
SMILES |
CC[C@H](C)/C=C(\C)/C=C/C1=CC2=C(C(=O)[C@]([C@@H](C2=CO1)O)(C)O)Cl
|
|
InChI |
InChI=1S/C19H23ClO4/c1-5-11(2)8-12(3)6-7-13-9-14-15(10-24-13)17(21)19(4,23)18(22)16(14)20/h6-11,17,21,23H,5H2,1-4H3/b7-6+,12-8+/t11-,17+,19+/m0/s1
|
|
InChIKey |
ZFOBGKZKFOAYTR-ZZSXOZOGSA-N
|
|
Synonyms |
Isochromophilone V; 167355-56-8; (7R,8R)-5-chloro-3-[(1E,3E,5S)-3,5-dimethylhepta-1,3-dienyl]-7,8-dihydroxy-7-methyl-8H-isochromen-6-one; 6H-2-Benzopyran-6-one, 5-chloro-3-(3,5-dimethyl-1,3-heptadienyl)-7,8-dihydro-7,8-dihydroxy-7-methyl; CHEMBL5085301
|
|
CAS | 167355-56-8 | |
PubChem CID | 6451017 | |
ChEMBL ID | CHEMBL5085301 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 350.8 | ALogp: | 3.2 |
HBD: | 2 | HBA: | 4 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 66.8 | Aromatic Rings: | 2 |
Heavy Atoms: | 24 | QED Weighted: | 0.744 |
Caco-2 Permeability: | -4.603 | MDCK Permeability: | 0.00002020 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.026 |
Human Intestinal Absorption (HIA): | 0.009 | 20% Bioavailability (F20%): | 0.003 |
30% Bioavailability (F30%): | 0.005 |
Blood-Brain-Barrier Penetration (BBB): | 0.853 | Plasma Protein Binding (PPB): | 88.25% |
Volume Distribution (VD): | 2.371 | Fu: | 12.11% |
CYP1A2-inhibitor: | 0.936 | CYP1A2-substrate: | 0.606 |
CYP2C19-inhibitor: | 0.879 | CYP2C19-substrate: | 0.385 |
CYP2C9-inhibitor: | 0.802 | CYP2C9-substrate: | 0.8 |
CYP2D6-inhibitor: | 0.897 | CYP2D6-substrate: | 0.114 |
CYP3A4-inhibitor: | 0.894 | CYP3A4-substrate: | 0.328 |
Clearance (CL): | 1.556 | Half-life (T1/2): | 0.423 |
hERG Blockers: | 0.034 | Human Hepatotoxicity (H-HT): | 0.484 |
Drug-inuced Liver Injury (DILI): | 0.803 | AMES Toxicity: | 0.95 |
Rat Oral Acute Toxicity: | 0.978 | Maximum Recommended Daily Dose: | 0.984 |
Skin Sensitization: | 0.931 | Carcinogencity: | 0.913 |
Eye Corrosion: | 0.015 | Eye Irritation: | 0.8 |
Respiratory Toxicity: | 0.972 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005435 | ![]() |
0.819 | D0B1IP | ![]() |
0.196 | ||
ENC005436 | ![]() |
0.819 | D05QDC | ![]() |
0.196 | ||
ENC005437 | ![]() |
0.781 | D0H6VY | ![]() |
0.190 | ||
ENC002178 | ![]() |
0.744 | D0E9KA | ![]() |
0.187 | ||
ENC001875 | ![]() |
0.600 | D0S7WX | ![]() |
0.186 | ||
ENC001841 | ![]() |
0.581 | D0Z1WA | ![]() |
0.186 | ||
ENC002612 | ![]() |
0.581 | D0C1SF | ![]() |
0.183 | ||
ENC005878 | ![]() |
0.551 | D0G3PI | ![]() |
0.183 | ||
ENC005844 | ![]() |
0.551 | D02DGU | ![]() |
0.183 | ||
ENC002010 | ![]() |
0.543 | D00DKK | ![]() |
0.183 |